BioCentury
BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Ep. 10 - EUAs, ACTIV & M&A 16.06.2020 17:20
Reach us by sending a text
Ep. 9 - IPOs, Vaccines & BIO's New Leader 08.06.2020 13:49
Reach us by sending a text
Ep. 8 - Financing Flurry & Purchasing Pools 01.06.2020 13:14
Reach us by sending a text
Ep. 7 - FDA takes on COVID-19, plus ASCO's breakthroughs 27.05.2020 15:37
Reach us by sending a text
Ep. 6 - New Faces for COVID-19’s Next Phase, ASCO’s Hot Topics 19.05.2020 18:02
Reach us by sending a text
Ep. 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19 12.05.2020 15:22
Reach us by sending a text
Ep. 4 - End of the beginning for vaccines and the post-pandemic future 05.05.2020 15:30
BioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future. Reach us by sending a text
Ep. 3 - Surveying the Landscape for Biopharmas 28.04.2020 14:33
BioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week. Reach us by sending a text
Ep. 2 - Consorting to beat COVID-19 23.04.2020 14:32
How industry, government and academics are joining together to discover, develop and deploy therapies and vaccines. Reach us by sending a text
Ep. 1 - Racing to Create Countermeasures 22.04.2020 16:02
It has been three months since Chinese scientists revealed the genomic sequence of SARS-CoV-2. In our first episode, “Racing to Create Countermeasures,” BioCentury’s editors discuss progress made by biopharma companies and other researchers in developing diagnostics, therapies and vaccines against the virus that causes COVID-19. Reach us by sending a text
Similar podcasts
Listen to the BioCentury This Week podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
